Form EFFECT Regulus Therapeutics
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | July 1, 2025 |
| Accession Number: | 0001104659-25-062437 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Chablis Capital Corp. and Viridian Metals Ireland Limited Close $3 Million of Its Subscription Receipts Financing in Connection with Proposed Qualifying Transaction
- Zero Debt Ranked as One of The Leading Debt Consolodation Companies in South Africa
- Cars.com Announces Inducement Awards Under NYSE Listing Rule 303A.08
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
